Extracellular vesicles produced by 3D cultured MSCs promote wound healing by regulating macrophage activation through ANXA1. 2024

Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
Medical School of Chinese PLA, Beijing, China.

The conundrum of wound healing has transformed into an imminent medical challenge. Presently, cell-free therapy centered around extracellular vesicles (EVs) has become a pivotal and promising research avenue. EVs generated from three-dimensional (3D) cell cultures have been previously established to possess enhanced tissue regeneration potential, although the underlying mechanisms remain elusive. In this study, we observed higher expression of annexin ANXA1 in 3D-cultured EVs. Remarkably, 3D-EVs with elevated ANXA1 expression demonstrated a more potent capacity to promote macrophage polarization from the M1 phenotype to the M2 phenotype. Concurrently, they exhibited superior abilities to enhance cell migration and tube formation, facilitating expedited wound healing in animal experiments. Conversely, the application of an ANXA1 inhibitor counteracted the positive effects of 3D-EVs. Taken together, our data validate that extracellular vesicles derived from 3D-cultured MSCs regulate macrophage polarization via ANXA1, thereby fostering wound healing.

UI MeSH Term Description Entries
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D000067128 Extracellular Vesicles Membrane limited structures derived from cell membranes and cytoplasmic material, and released into EXTRACELLULAR SPACE. They circulate through the EXTRACELLULAR FLUID and through the peripheral blood in the MICROVASCULATURE where cells, much larger, cannot, thereby affecting a variety of intercellular communication processes. Apoptotic Bodies,Exovesicles,Apoptotic Body,Bodies, Apoptotic,Body, Apoptotic,Exovesicle,Extracellular Vesicle,Vesicle, Extracellular,Vesicles, Extracellular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D018929 Cell Culture Techniques Methods for maintaining or growing CELLS in vitro. Cell Culture,Cell Culture Technique,Cell Cultures,Culture Technique, Cell,Culture Techniques, Cell

Related Publications

Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
October 2022, Hypertension (Dallas, Tex. : 1979),
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
May 2023, Journal of diabetes and its complications,
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
March 2023, Molecular therapy. Nucleic acids,
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
March 2023, Bioactive materials,
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
May 2019, Clinical science (London, England : 1979),
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
May 2023, Life sciences,
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
April 2017, The Journal of investigative dermatology,
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
September 2017, Scientific reports,
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
August 2021, Pharmaceuticals (Basel, Switzerland),
Hao Deng, and Yuheng Jiang, and Junhao Deng, and Feifan Chang, and Junyu Chen, and Xinyu Sun, and Dongliang Cheng, and Zhongqi Wang, and Ran Li, and Jiang Liu, and Yi Li, and Licheng Zhang, and Pengbin Yin
March 2021, Stem cells (Dayton, Ohio),
Copied contents to your clipboard!